Cargando…

Disparities in clinical features and outcomes of peripartum cardiomyopathy in high versus low prevalent regions in Nigeria

AIMS: The prospective, multicentre Peripartum Cardiomyopathy in Nigeria (PEACE) registry originally demonstrated a high prevalence of peripartum cardiomyopathy (PPCM) among patients originating from Kano, North‐West Nigeria. In a post hoc analysis, we sought to determine if this phenomenon was chara...

Descripción completa

Detalles Bibliográficos
Autores principales: Karaye, Kamilu M., Ishaq, Naser A., Sai'du, Hadiza, Balarabe, Sulaiman A., Ahmed, Bashir G., Adamu, Umar G., Mohammed, Idris Y., Oboirien, Isa, Umuerri, Ejiroghene M., Mankwe, Abaram C., Shidali, Vincent Y., Dodiyi‐Manuel, Sotonye, Njoku, Paschal, Olunuga, Taiwo, Josephs, Veronica, Mbakwem, Amam C., Ogah, Okechukwu S., Tukur, Jamilu, Okeahialam, Basil, Stewart, Simon, Henein, Michael, Sliwa, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318483/
https://www.ncbi.nlm.nih.gov/pubmed/34137499
http://dx.doi.org/10.1002/ehf2.13463
_version_ 1783730254849769472
author Karaye, Kamilu M.
Ishaq, Naser A.
Sai'du, Hadiza
Balarabe, Sulaiman A.
Ahmed, Bashir G.
Adamu, Umar G.
Mohammed, Idris Y.
Oboirien, Isa
Umuerri, Ejiroghene M.
Mankwe, Abaram C.
Shidali, Vincent Y.
Dodiyi‐Manuel, Sotonye
Njoku, Paschal
Olunuga, Taiwo
Josephs, Veronica
Mbakwem, Amam C.
Ogah, Okechukwu S.
Tukur, Jamilu
Okeahialam, Basil
Stewart, Simon
Henein, Michael
Sliwa, Karen
author_facet Karaye, Kamilu M.
Ishaq, Naser A.
Sai'du, Hadiza
Balarabe, Sulaiman A.
Ahmed, Bashir G.
Adamu, Umar G.
Mohammed, Idris Y.
Oboirien, Isa
Umuerri, Ejiroghene M.
Mankwe, Abaram C.
Shidali, Vincent Y.
Dodiyi‐Manuel, Sotonye
Njoku, Paschal
Olunuga, Taiwo
Josephs, Veronica
Mbakwem, Amam C.
Ogah, Okechukwu S.
Tukur, Jamilu
Okeahialam, Basil
Stewart, Simon
Henein, Michael
Sliwa, Karen
author_sort Karaye, Kamilu M.
collection PubMed
description AIMS: The prospective, multicentre Peripartum Cardiomyopathy in Nigeria (PEACE) registry originally demonstrated a high prevalence of peripartum cardiomyopathy (PPCM) among patients originating from Kano, North‐West Nigeria. In a post hoc analysis, we sought to determine if this phenomenon was characterized by a differential case profile and outcome among PPCM cases originating elsewhere. METHODS AND RESULTS: Overall, 199 (81.6%) of a total 244 PPCM patients were recruited from three sites in Kano, compared with 45 patients (18.4%) from 11 widely dispersed centres across Nigeria. Presence and extent of ventricular myocardial remodelling during follow‐up, relative to baseline status, were assessed by echocardiography. During median 17 months follow‐up, Kano patients demonstrated significantly better myocardial reverse remodelling than patients from other sites. Overall, 50.6% of patients from Kano versus 28.6% from other regions were asymptomatic (P = 0.029) at study completion, with an accompanying difference in all‐cause mortality (17.6% vs. 22.2% respectively, P = 0.523) not reaching statistical significance. Alternatively, 135/191 (84.9%) of Kano patients had selenium deficiency (<70 μg/L), and 46/135 (34.1%) of them received oral selenium supplementation. Critically, those that received selenium supplementation demonstrated better survival (6.5% vs. 21.2%; P = 0.025), but the supplement did not have significant impact on myocardial remodelling. CONCLUSIONS: This study has shown important non‐racial regional disparities in the clinical features and outcomes of PPCM patients in Nigeria, that might partly be explained by selenium supplementation.
format Online
Article
Text
id pubmed-8318483
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83184832021-07-31 Disparities in clinical features and outcomes of peripartum cardiomyopathy in high versus low prevalent regions in Nigeria Karaye, Kamilu M. Ishaq, Naser A. Sai'du, Hadiza Balarabe, Sulaiman A. Ahmed, Bashir G. Adamu, Umar G. Mohammed, Idris Y. Oboirien, Isa Umuerri, Ejiroghene M. Mankwe, Abaram C. Shidali, Vincent Y. Dodiyi‐Manuel, Sotonye Njoku, Paschal Olunuga, Taiwo Josephs, Veronica Mbakwem, Amam C. Ogah, Okechukwu S. Tukur, Jamilu Okeahialam, Basil Stewart, Simon Henein, Michael Sliwa, Karen ESC Heart Fail Original Research Articles AIMS: The prospective, multicentre Peripartum Cardiomyopathy in Nigeria (PEACE) registry originally demonstrated a high prevalence of peripartum cardiomyopathy (PPCM) among patients originating from Kano, North‐West Nigeria. In a post hoc analysis, we sought to determine if this phenomenon was characterized by a differential case profile and outcome among PPCM cases originating elsewhere. METHODS AND RESULTS: Overall, 199 (81.6%) of a total 244 PPCM patients were recruited from three sites in Kano, compared with 45 patients (18.4%) from 11 widely dispersed centres across Nigeria. Presence and extent of ventricular myocardial remodelling during follow‐up, relative to baseline status, were assessed by echocardiography. During median 17 months follow‐up, Kano patients demonstrated significantly better myocardial reverse remodelling than patients from other sites. Overall, 50.6% of patients from Kano versus 28.6% from other regions were asymptomatic (P = 0.029) at study completion, with an accompanying difference in all‐cause mortality (17.6% vs. 22.2% respectively, P = 0.523) not reaching statistical significance. Alternatively, 135/191 (84.9%) of Kano patients had selenium deficiency (<70 μg/L), and 46/135 (34.1%) of them received oral selenium supplementation. Critically, those that received selenium supplementation demonstrated better survival (6.5% vs. 21.2%; P = 0.025), but the supplement did not have significant impact on myocardial remodelling. CONCLUSIONS: This study has shown important non‐racial regional disparities in the clinical features and outcomes of PPCM patients in Nigeria, that might partly be explained by selenium supplementation. John Wiley and Sons Inc. 2021-06-17 /pmc/articles/PMC8318483/ /pubmed/34137499 http://dx.doi.org/10.1002/ehf2.13463 Text en © 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research Articles
Karaye, Kamilu M.
Ishaq, Naser A.
Sai'du, Hadiza
Balarabe, Sulaiman A.
Ahmed, Bashir G.
Adamu, Umar G.
Mohammed, Idris Y.
Oboirien, Isa
Umuerri, Ejiroghene M.
Mankwe, Abaram C.
Shidali, Vincent Y.
Dodiyi‐Manuel, Sotonye
Njoku, Paschal
Olunuga, Taiwo
Josephs, Veronica
Mbakwem, Amam C.
Ogah, Okechukwu S.
Tukur, Jamilu
Okeahialam, Basil
Stewart, Simon
Henein, Michael
Sliwa, Karen
Disparities in clinical features and outcomes of peripartum cardiomyopathy in high versus low prevalent regions in Nigeria
title Disparities in clinical features and outcomes of peripartum cardiomyopathy in high versus low prevalent regions in Nigeria
title_full Disparities in clinical features and outcomes of peripartum cardiomyopathy in high versus low prevalent regions in Nigeria
title_fullStr Disparities in clinical features and outcomes of peripartum cardiomyopathy in high versus low prevalent regions in Nigeria
title_full_unstemmed Disparities in clinical features and outcomes of peripartum cardiomyopathy in high versus low prevalent regions in Nigeria
title_short Disparities in clinical features and outcomes of peripartum cardiomyopathy in high versus low prevalent regions in Nigeria
title_sort disparities in clinical features and outcomes of peripartum cardiomyopathy in high versus low prevalent regions in nigeria
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318483/
https://www.ncbi.nlm.nih.gov/pubmed/34137499
http://dx.doi.org/10.1002/ehf2.13463
work_keys_str_mv AT karayekamilum disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT ishaqnasera disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT saiduhadiza disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT balarabesulaimana disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT ahmedbashirg disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT adamuumarg disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT mohammedidrisy disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT oboirienisa disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT umuerriejiroghenem disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT mankweabaramc disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT shidalivincenty disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT dodiyimanuelsotonye disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT njokupaschal disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT olunugataiwo disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT josephsveronica disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT mbakwemamamc disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT ogahokechukwus disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT tukurjamilu disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT okeahialambasil disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT stewartsimon disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT heneinmichael disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT sliwakaren disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria
AT disparitiesinclinicalfeaturesandoutcomesofperipartumcardiomyopathyinhighversuslowprevalentregionsinnigeria